Pill Connect expands its team with the appointment of Richard Hall as Director of Quality

Written by: Nola Cadman
Published on: 16 Dec 2020

Pill Connect (formerly known as Elucid Mhealth), a world leader in medicine adherence monitoring and data capture on patient compliance, has expanded its team with the appointment of Richard Hall as Director of Quality. This follows the recent successful funding raise involving the investment serial entrepreneur Jonathan Milner, Catapult Ventures and Shallcross Partners and is the next step as Pill Connect moves towards commercialisation.

Richard has 27 years’ experience of Quality Management and New Product Development within the medical device  industry. As founder and Director of QMS Consultancy Ltd Richard has helped 50+ companies worldwide to achieve their quality and regulatory goals, accelerating their route to market. Richard has lectured at Imperial College London and spoken at Oxford, Manchester and Liverpool universities as well as The National Physics Laboratory and multiple accelerators throughout the UK. As a trained Lead Auditor himself, Richard has helped his clients pass 72 Notified Body audits and understands what is required for a successful ISO 13485 & MDSAP assessment. Richard has also written product technical files gaining the CE mark for multiple devices.

CEO of Pill Connect James Burnstone Commented “We are delighted that Richard has joined our team as Director of Quality. His unique approach, vast knowledge and extensive expertise in this area has allowed us to implement a comprehensive ISO 13485 QMS in just one month, enabling us to move forward with our proven technology into the commercial phase of development. Throughout the whole implementation experience, Richard has been a pleasure to work with and we anticipate and look forward to a long and productive relationship with him.”

Pill Connect has developed a smart pill dispensing solution which will allow both trial investigators and doctors to effectively monitor medication adherence in real time, either in clinical trials or in the community. Pill Connect is in discussions with several top tier Pharmas, CROs, and CMOs all of whom all keen to find effective ways to monitor and improve patient adherence through the accurate collection of patient behaviour data. According to figures from the OECD1 poor medication adherence contributes to nearly 200,000 premature deaths in Europe every year.

How it works

The Pill Connect system prompt patients to take their medications on time and to send a report back to the doctor to advise them of their patient’s adherence record.   The prompt comes from an app on their mobile phone which when acknowledged dispenses a pill or capsule from the bottle through the smart dispensing cap. Should the patient not wish to take their medication due to illness or an adverse reaction they can respond through the app.

About Pill Connect

Pill Connect, which until recently was called Elucid mHealth, is a health technology company based in Manchester, UK developing smart solutions to improve patient adherence and provide accurate patient data to the industry, regulators and doctors. Pill Connect’s smart dispensing system has already proven its robustness and ability to interact with patients in real time and improve adherence through a series of clinical trials involving CROs, pharma companies and The Medication Adherence Expertise Center at the University of Groningen in the Netherlands.

For more information about Pill Connect click here